HIM
ANGO icon

Hillsdale Investment Management’s AngioDynamics ANGO Stock Holding History

Hillsdale Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,200
Closed -$426K – 656
2025
Q4 		$426K Hold
33,200
– – 0.01% 445
2025
Q3 		$371K Buy
33,200
+32,500
+4,643% +$314K 0.01% 442
2025
Q2 		$6.94K Buy
700
+150
+27% +$1.47K ﹤0.01% 556
2025
Q1 		$5.17K Buy
+550
New +$5.78K ﹤0.01% 572
2017
Q2 		– Sell
-65,630
Closed -$1.14M – 466
2017
Q1 		$1.14M Sell
65,630
-17,000
-21% -$284K 0.23% 82
2016
Q4 		$1.39M Buy
+82,630
New +$1.38M 0.29% 57

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Hillsdale Investment Management's ANGO Position: Q1 2026 in Review

Hillsdale Investment Management sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 33,200 shares — an estimated $426K sold.

Hillsdale Investment Management first reported a position in ANGO in Q4 2016 and held it in 6 quarters. The position peaked at $1.39M in Q4 2016. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Hillsdale Investment Management reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • Hillsdale Investment Management sold 33,200 AngioDynamics shares in Q1 2026, an estimated $426K.
  • Hillsdale Investment Management first reported a position in AngioDynamics in Q4 2016 and held it in 6 quarters.
  • Hillsdale Investment Management's AngioDynamics position peaked at $1.39M in Q4 2016.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.